💊FDA PHARMA today

💊FDA PHARMA today

百时美施贵宝公司获得积极的CHMP意见,建议批准Yervoy(伊匹单抗)用于治疗12岁及以上不能切除或转移性黑色素瘤的儿科患者| BMS新闻室

http://www.ono.co.jp/jpnw/PDF/n17_1218.pdf

https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-receives-positive-chmp-opinion-recommendi